GE HealthCare Technologies GEHC Product — Effects of cash flow hedges
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by GE HealthCare Technologies in its filing.
Tagged under the XBRL concept us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax.
The official record: GE HealthCare Technologies’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about GE HealthCare Technologies's product — effects of cash flow hedges.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is GE HealthCare Technologies's product — effects of cash flow hedges?
- GE HealthCare Technologies (GEHC) reported product — effects of cash flow hedges of $5M in Q1 2026.
- How has GE HealthCare Technologies's product — effects of cash flow hedges changed year-over-year?
- GE HealthCare Technologies's product — effects of cash flow hedges increased by 350.0% year-over-year, from -$2M to $5M.
- What is the long-term trend for GE HealthCare Technologies's product — effects of cash flow hedges?
- Over 4 years (2021 to 2025), GE HealthCare Technologies's product — effects of cash flow hedges has grown at a 22.5% compound annual growth rate (CAGR), from -$8M to $18M.
- What does product — effects of cash flow hedges mean?
- Reflects the impact of financial instruments used to mitigate the risk of variability in cash flows associated with highly probable forecasted transactions, such as foreign currency exposure. These adjustments reconcile the difference between the hedged rate and the market rate at the time of settlement.